We are live on
!
Find out more
NLVP
New Leaf Venture Partners Portfolio holdings
AUM
$43M
1-Year Est. Return
25.55%
This Fund
S&P 500
This Quarter
Est. Return
-5.6%
1 Year Est. Return
-25.55%
3 Year Est. Return
+17.13%
5 Year Est. Return
+114.46%
10 Year Est. Return
+1,011.57%
AUM
$52.9M
AUM Growth
+$8.05M
(+18%)
Cap. Flow
-$1.01M
Cap. Flow
% of AUM
-1.9%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rocket Pharmaceuticals
RCKT
|
+$1.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
BAM
MAM
WCPI
WAMC
CC
CIEP
IPI
VSAM
New Leaf Venture Partners's Q2 2025 Portfolio in Review
As of Q2 2025, New Leaf Venture Partners held 9 positions worth $52.9M, up 18% from $44.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
New Leaf Venture Partners's Q2 2025 filing shows 1 closed position. The largest sale was Rocket Pharmaceuticals, an estimated $1.01M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- New Leaf Venture Partners fully exited Rocket Pharmaceuticals in Q2 2025, selling an estimated $1.01M.
- New Leaf Venture Partners's ten largest holdings make up 100% of its $52.9M portfolio in Q2 2025.
- New Leaf Venture Partners opened 0 new positions and closed 1 in Q2 2025.
- New Leaf Venture Partners's portfolio value rose 18% quarter-over-quarter to $52.9M.
Based on New Leaf Venture Partners's 13F filing for Q2 2025, filed 13 Aug 2025.